HELICE is pioneering financial engineering on the Ethereum blockchain, with the goal of halving the cost of high-tech prosthetics and artificial organs.

These advanced technologies, such as retinal implants, prosthetic arms, neuroprosthetics, artificial hearts, and exoskeletons, currently cost around $100,000, with slow development due to the challenges of personalized production and long revenue cycles for biotech companies, often taking up to 10 years. This limits investment and delays progress. Helice’s approach aims to break this cycle by reducing costs and driving capital into our future lab, accelerating the innovation and accessibility of these critical technologies.